The molecule target brings the new hope to lung cancer

The molecule target brings the new hope to lung cancer treatment in later period to the medicine
Author: The king Lu Pan's sharp point

Expert media common understanding can scene Lu Wang /take a photograph of to announce by the third coroner's inquest situations mains national April 29 such as Ministry of Public Health, the investigation result shows, lung cancer, hepatocarcinoma, form rectal cancer, breast cancer, bladder cancer mortality and form, show a tendency to obviously rise related to environment, life style, among them it is at the largest range that lung cancer rises, have risen by 465% in the past 30 years. And, the first ten malignant tumour form, come, watch from urban and rural areas, lung cancer become of our country first the intersection of malignant tumour and the intersection of death and reason (account for all the intersection of malignant tumour and 22.7% of death) instead of hepatocarcinoma already .

On November 4, prevent and cotrol the office, Chinese Anti-Cancer Association to sponsor at disease of Ministry of Public Health, Shanghai Roche Group Co., Ltd. jointly initiated " The dialogue hopes - -Pay close attention to the Chinese lung cancer treatment " At the news conference of the theme, the popular science minister of work office of Chinese Anti-Cancer Association props up and repairs a benefit professor to point out: "As to lung cancer patient, find, it is very crucial to treat early early. Early symptom of lung cancer have very high disguise, about 70% the intersection of person who didn't get cellule lung cancer and some later period already find ill, or shift. The molecule target is to the appearance of the medicine, in order to overcome it is not that cellule lung cancer brings more confidence in victory. "

The molecule target is to the medicine, the new treatment of lung cancer

In the past, once chemotherapy failed, patients often gave up treating. And target to treat, direct a certain cancer cell against, direct a certain albumen, a certain molecule of cancer cell against, go on, treat, it can distinguish enemy and friend, has a little effect on health cell while killing tumour cells. The newest data reveal: Asian survival rate up to 60% one year in patient such as lung cancer, location of middle there nearly 25.1 weeks. Molecule target, to treat as one new treatment, bring to lung cancer patient in later period enormous to hope.

According to the introduction of Vice President, far triumphant professor of stone of head of the department of internal medicine of tumour in the tumour hospital of Chinese Academy of Medical Sciences, being used is not cellule two / therapeutic special Luo Kai (strategic point Lip river take the place of the Buddhist nun) of the the strategic hinterland of China after the chemotherapy previously fails of lung cancer in later period It is a biological target of a innovation to anticancer drug, can lengthen the person who didn't get cellule lung cancer's life cycle of later period notably, make survival rate up to 60% one year in patient such as lung cancer, this lung cancer treat best data of field in recent years too. In November of 2004, special Luo got approval of U.S.A. FDA triumphantly, and was approved by European Union and listed in September of 2005. National food and medicines in China have supervised the administration bureau issuing importing the medicines licence triumphantly for special Luo on April 6, 2006.

"Special Luo acts on tumour cells triumphantly and pointedly, inhibit its growth, hyperplasia, thus prevent tumour cells from growing, can delay the deterioration of lung cancer and relevant symptom such as coughing, dyspnea, pain, strong side effects such as leucocyte decline, nausea preventing traditional chemotherapy from causing, vomiting,etc., and only need to take orally once every day and improve the patient's life quality notably. " The stone is far told reporters triumphantly.

Treat keywords: Standardization, individual, totalization

As to lung cancer patient, the basic purpose to treat is to control some recurring of tumour and distant place to shift, improve patient's life quality, lengthen life cycle. So, " three melt and give consideration to " in the individual, totalization, standardized Healing solution getting more important very,it is single in any be effective in treatments unstandards. This is that internal medicine department of tumour hospital of Beijing breathes inpatient area director Professor Wang Jie to put forward at the meeting.

According to the pathologic type, lung cancer can be divided into cellule lung cancer and not cellule lung cancer. That occupied 80% in lung cancer is not that cellule lung cancer include scale's cancer, gland cancer, great cell cancer,etc. again. According to the condition progress, each kind of type lung cancer is divided into early, middle, late to leave one again, different kinds of, different issues of other lung cancer, its healing solution has obvious difference. In addition each health of patient various, sometimes even the same type, with the first stage of other lung cancer, as to different patients, its healing solution is totally different too. So, should direct against each patient's situation, make and include the surgery, chemotherapy, radiotherapy, innovative target in individual's comprehensive healing solution inside to many kinds of treatment means such as anticancer drug, and integrated network the intersection of cellule and the intersection of lung cancer and the intersection of clinical practice and guide according to the intersection of U.S.A. and cancer ' China edition) Treat. The expert still encourages all lung cancer patients to cooperate with doctor actively, look for the suitable anticancer weapon.

The stone is far proposed triumphantly, because the administration method from target to treatment medicine is very simple, the patient probably realizes the therapeutic hope at home, has not merely saved the expenses in hospital, security is secure too. The time of result is generally on 9~14 days that the target arises to the medicine, patients will get obvious improvement at this period of time symptom. Go on the target at home to the patient treating, should go to the hospital to reexamine and carry on the assessment of curative effect one month later, for example check the size of lymph node, size change in the lump, and the serum tumour mark drops etc..

What patients are suitable for treating to the medicine with the target?

Target although have unique advantages to treat, have not totally replaced traditional chemotherapy, chemotherapy applicable scope wide comparatively, to treat have particular the intersection of adaptation and crowd their target, and not every the intersection of lung cancer and patient have an opportunity, carry on target to treat.

Stone point out by the look of clinical observation, to treat and suit the person who didn't get cellule lung cancer mainly target while being triumphant far, this kind of patients nearly account for 80%. In treating the opportunity, the first-selected surgery of early lung cancer, has already lost later period lung cancer of the surgery chance, its therapeutic principle carries on chemotherapy first ' Namely a gleam of treatment) ,If fail and carry on the treatment of Line two, the strategic hinterland of China again. The target is to two, treatment of the strategic hinterland of China treating and mainly used for the first line and treating the loser, security is higher, patient's life quality is better. In addition, lung cancer patient of advanced age, some later period, and some physique is too more badly to fit for the chemotherapy or unwilling person who accept chemotherapy, can also carry on the target to the treatment.

Which side effect to the medicine of the traditional chemotherapy &'s target is great?

Prop up and repair the benefit introduction, compared with method of other therapeutic lung cancer, the target can attack the cancer cell to the most prominent advantage of drug therapy accurately and don't injure normal cells; It can aim at some targets (the signal with characterized tumour will conduct thorough fare or new born blood vessel,etc.) just like high and perfect guided missile ,Eliminate the cancer cell directly, will seldom accidentally injure the normal cells of organism. So, the poisonous side reaction of the person who treats future trouble is relatively small, have diarrhoea, rash,etc. commonly, but will not drop etc. and react seriously, improve the patient's life quality depilating, leucocyte.

Traditional chemotherapy does not distinguish the good from the bad a bit, just like bomb, bomb a film, having not only kill the cancer cell but also injured normal cells, so poisonous side reaction is very great after much patient chemotherapy, for example reflect the gastrointestinal tract, depilate, the leucocyte, blood platelet drop etc., serious poisonous side reaction will also destroy the human immune system, it is even fatal sometimes.

The far triumphant professor of stone thinks, in the near future, lung cancer is expected to really turn into a chronic disease in later period, like diabetes, hypertension patient, take medicine at home under the guidance of doctor, the condition can be controlled, taken cancer to survive for a long time.

Chain: Readers can log in to the dialogue and hope in the official site: www.duihuaxiwang.cn reads the consultation about making a diagnosis in tumour. CCTV- 2 the intersection of way and program of health invite stone to be far triumphant discussing lung cancer prevent and cure live by two Professor by one dragon Wu on will it be the beginning December.

The molecule target brings the new hope to lung cancer treatment in later period to the medicine